SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-004675
Filing Date
2005-08-11
Accepted
2005-08-11 16:42:31
Documents
9
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b55527ape10vq.htm 10-Q 414296
2 EX-3.1 RESTATED CERTIFICATE OF INCORPORATION b55527apexv3w1.txt EX-3.1 56667
3 EX-10.3 FORMS OF INCENTIVE STOCK OPTION b55527apexv10w3.txt EX-10.3 15017
4 EX-10.6 AMENDMENT NO. 1 TO DATED AUGUST 2,2004 b55527apexv10w6.txt EX-10.6 3499
5 EX-10.8 AGREEMENT GARCHING INNOVATION GMBH b55527apexv10w8.txt EX-10.8 22760
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b55527apexv31w1.txt EX-31.1 4125
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b55527apexv31w2.txt EX-31.2 4097
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b55527apexv32w1.txt EX-32.1 1470
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b55527apexv32w2.txt EX-32.2 1441
  Complete submission text file 0000950135-05-004675.txt   524834
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 051017604
SIC: 2834 Pharmaceutical Preparations